Stephen G. Jenkins, Ph.D.

Stephen Jenkins

Stephen G. Jenkins, Ph.D., a clinical microbiologist for over 33 years, currently serves as Director of the Clinical Microbiology Laboratories at New York Presbyterian Hospital Hospital/Weill Cornell Medical Center and as a Professor in the Department of Pathology and Laboratory Medicineas well as a Professor of Pathology in Medicine at the Weill Cornell Medical College in New York, NY.

Dr Jenkins obtained his Ph.D. in Medical Microbiology at the University of Vermont and did his postdoctoral residency in Clinical and Public Health Microbiology at the Mount Sinai Medical Center in Milwaukee, WI.

In addition to his current appointment, Dr. Jenkins has held past faculty appointments as Professor of Pathology and Professor of Medicine at the Mount Sinai School of Medicine in New York, NY, as an Associate Professor of Pathology and as an Associate Professor of Medicine at the University of Florida College of Medicine as well as serving as Global Director of Microbiology and interim Global Director of Anti-infectives for Aventis Pharmaceuticals, in which capacity he was largely involved in the clinical trials and successful FDA submission of the antimicrobial agent telithromycin.

Dr. Jenkins has published 15 textbook chapters and served as a section editor for the the Clinical Microbiology Procedures Handbook. Additionally he has co-authored fourteen CLSI Standards, authored or co-authored over 115 articles in such peer-reviewed journals as Emerging Infectious Diseases, the Journal of Antimicrobial Chemotherapy, the Journal of Medical Microbiology, Transplantation, Pediatrics, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Reviews in Medical Microbiology, Clinical Nephrology; the Annals of Otology, Rhinology, and Laryngology, Diagnostic Microbiology and Infectious Disease, the Southern Medical Journal, Obstetrics and Gynecology, the Journal of Clinical Microbiology, the European Journal of Clinical Microbiology and Infectious Diseases, the Pediatric Infectious Disease Journal, the Journal of Infectious Diseases, the British Journal of Haematology, and the American Journal of Medicine. In addition he has authored 21 monographs and invited articles and 131 abstracts, presented at national and international professional society meetings.

Dr. Jenkins lectures widely, both nationally and internationally, and in 2004 was an invited speaker for the National Foundation for Infectious Diseases both at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Disease Society of America (IDSA) annual meetings.

Dr. Jenkins has served as a Reviewer for a number of professional journals including the Journal of Clinical Microbiology, the Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, the Annals of Internal Medicine, Digestive Diseases, Clinical Microbiology Reviews, the International Journal of Antimicrobial Agents, Clinical Microbiology and Infection, ASM News, Anaerobe, Mayo Clinic Proceedings, and Diagnostic Microbiology and Infectious Diseases, and currently serves on the Editorial Board of the journal Anaerobe.

A Fellow of the American Academy of Microbiology and a Diplomate of the American Board of Medical Microbiology in Public Health and Medical Microbiology, he  additionally holds or has held a host of positions in professional organizations and societies including Chairman of the American Board of Medical Microbiology, the Board of Governors of the American Academy of Microbiology; Chairman of the American Board of Medical Microbiology Standards and Examination Committee, Chairman of Division C (Clinical Microbiology) of the American Society for Microbiology; the Clinical Laboratory Standards Institute (CLSI) Area Committee on Microbiology, the CLSI Subcommittee on Antimicrobial Susceptibility Testing (SAST), the CLSI SAST Working Group on Anaerobes, the CLSI SAST Working Group on the Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data, the CLSI SAST Working Group on Clinical Studies, as chair of the CLSI SAST Enterobacteriaceae Working Group and currently as co-chair of the CLSI SAST Methodology Working Group and a member of  the ICAAC Program Committee.

Publications

Fusco DN, Alexander EL, Weisenberg SA, Mediavilla JR, Kreiswirth BN, Schuetz AN, Jenkins SG, Rhee KY. 2009. Clinical Failure in a Dialysis Patient with hVISA MSSA.  Accepted for publication in: Diagnostic Microbiology and Infectious Diseases.

Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJC, Harrell L, Jenkins SG, Newton D, Pierson C, Rihs J, Yu VL, Venezia R, Iannini P, Finegold SM and Gorbach SL. 2009. Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data 2005–2007. Accepted for Publication in: Clinical Infectious Diseases.

Pastagia M, Mullen M, Jenkins SG, Schaberg M. 2009. Unusual Presentation of Salmonella Infection in Two Diabetic Patients. Accepted for Publication in: Infections in Medicine.

Jenkins SG, Farrell DJ. 2009. A Significant Increase in Pneumococcal Macrolide Resistance in the USA. Emerging Infectious Diseases.  Vol. 15: 1260 – 1264.

Lee J, Huprikar S, Jenkins SG. 2009. Are Patients with POEMS Syndrome at Increased Risk of Salmonella Aortitis? Int J Infect Dis. Vol. 13: e97-99.

Lee J, Patel G, Huprikar S, Calfee DP, Jenkins SG. 2009. Decreased Susceptibility of Polymyxin B During Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection. Journal of Clinical Microbiology. Vol. 47: 1611 – 1612.

Endimiani A, Hujer AM,Perez F, Bethel CR, Hujer KM,  Kroeger J, Oethinger M,  Paterson DL, Adams MD,  Jacobs MR, Diekema DJ, Hall GG, Jenkins SG, Rice LB, Tenover FC, Bonomo AR. 2009. Characterization of blaKPC-containing Klebsiella pneumoniae Isolates Detected in Different Institutions in the Eastern United States. Journal of Antimicrobial Chemotherapy. Vol. 63: 427-437.

Jenkins SG. 2008. Antimicrobial Susceptibility Patterns in the United States and Globally: Findings of the TRUST and GLOBAL Surveillance Studies. Postgraduate Medicine. Sep; 120 (3 Suppl 1): 5-7.

Calfee DP, Jenkins SG. 2008. Surveillance Cultures to Detect Asymptomatic Colonization with Carbapenem-Resistant Klebsiella pneumoniae among Intensive Care Unit Patients. Infection Control and Hospital Epidemiology. Vol.10: 966-968.
 
Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. 2008. Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies. Infection Control and Hospital Epidemiology. Vol. 29: 1099-1106.
 
 

Endimiani A, Carias LL, Hujer AM, Bethel CR, Hujer KM, Perez F, Hutton RA, Fox WR, Hall GS, Jacobs MR, Peterson DL, Rice LB, Jenkins SG, Tenover FC, Bonomo RA. 2008. Emergence of Plasmid-mediated Quinolone Resistance in Klebsiella pneumoniae Possessing blaKPC in the United States. Antimicrob Agents Chemother. Vol. 52:2680#150;2682.

 

Jenkins SG, Brown SD, Farrell DJ. 2008. Trends in Antibacterial Resistance among Streptococcus pneumoniae Isolates in the USA: Update from PROTEKT US Years 1-4. Annals of Clinical Microbiology and Antimicrobials. Vol. 7:1-11.

 

Felmingham D, Canton R, Jenkins SG. 2007. Regional Trends in Beta-Lactam, Macrolide, Fluoroquinolone, and Telithromycin Resistance among Streptococcus pneumoniae isolates 2001-2004. J Infection. Vol. 55:111-118.

 

Petersen BE, Jenkins SG, Yuan S, Lamm C, Rosenberg HK, Szporn AH. 2007. Nocardia farcinica Isolated from Bronchoalveolar Lavage Fluid of a Child with Cystic Fibrosis. The Pediatric Infectious Disease Journal. Vol. 26:858-859.

 

Bottone EJ, Reyes M, Jenkins SG. 2007. Rapid Detection and Identification of Methicillin Resistant Staphylococcus aureus Directly from Positive Blood Cultures Exhibiting Gram-Positive Cocci in Clusters. Clinical Microbiology Newsletter. Vol. 29:137-139.

 

Calfee DP, Kornblum J, Jenkins SG. 2007. A Pseudo-Outbreak of Bordetella bronchiseptica Infections Associated with Contaminated Rabbit Blood Used as a Microbiology Culture Medium Supplement. Infection Control and Hospital Epidemiology. Vol. 28:758-760.

 

Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJ, Finegold SM, Harrell LJ, Hecht DW, Jenkins SG, Oierson C, Venezia R, Yu V, Rihs J, Gorbach SL. 2007. National Survey on the Susceptibility of B. fragilis Group: Report and Analysis of Trends for 1997 #150; 2004: A US Survey. Antimicrob Agents Chemother. Vol. 51:1649-1655.

 

Farrell DJ, File TM, Jenkins SG. 2007. Prevalence and Antibacterial Susceptibility of mef(A)-positive Macrolide-resistant Streptococcus pneumoniae Over 4 years of the PROTEKT US Study (2000-2004). J Clin Microbiol. Vol. 45:290-293.

 

Kasowitz AR, McCusker M, Coury-Doniger P, Neal WP, Indyk D, Burk RD, Jenkins SG, Rickert VI, Herold BC. 2006. Stage of Change Behavioral Assessment Tool Fails to Predict the Prevalence of Chlamydia in an Urban Adolescent Health Clinic. J Pediatr Adolesc Gynecol. Vol. 2019:277-83.

 

Fakioglu E, Queenan AM, Bush K, Jenkins SG, Herold BC. 2006. Amp C Beta-Lactamase Producing E. coli in Neonatal Meningitis: Diagnostic and Therapeutic Challenge. J Perinatology. Vol. 26:515-517.

 

Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, Adinoff AD, Bachert C, Borish L, Chinchilli VM, Danzig MR, Ferguson BJ, Fokkens WJ, Jenkins SG, Lund VJ, Mafee MF, Naclerio RM, Pawankar R, Ponikau JU, Schubert MS, Slavin RG, Stewart MG, Togias A, Wald ER, Winther B. 2006. Rhinosinusitis: Developing Guidance for Clinical Trials. Journal of Allergy and Clinical Immunology. 118(5 Suppl):S17-61.

 

Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, Adinoff AD, Bachert C, Borish L, Chinchilli VM, Danzig MR, Ferguson BJ, Fokkens WJ, Jenkins SG, Lund VJ, Mafee MF, Naclerio RM, Pawankar R, Ponikau JU, Schubert MS, Slavin RG, Stewart MG, Togias A, Wald ER, Winther B. 2006. Rhinosinusitis: Developing Guidelines for Clinical Trials. Journal of Otolaryngology - Head and Neck Surgery. Vol. 135 (5 Suppl):S31-80.

 

Jenkins SG. 2006. In Vitro Susceptibility Testing for the New Ketolide Antibacterial Telithromycin - Influence of Methodological Factors. Clinical Microbiology Newsletter. Vol. 28:137-142.

 

Jenkins SG, Farrell DJ, Patel M, Lavin BS. 2005. Trends in Anti-bacterial Resistance Among Streptococcus pneumoniae Isolated in the USA, 2000#150;2003: PROTEKT Years 1#150;3. Journal of Infection. Vol. 51:355-363.

 

Farrell DJ, Jenkins SG, Brown SD, Patel M, Lavin BS, Klugman, KP. 2005. Global Spread and Increasing Prevalence in the USA of Multi-resistant Streptococcus pneumoniae clonal complex 271 (Taiwan19F-1) with Both erm(B) and mef(A) Encoded Macrolide Resistance. Emerging Infectious Diseases. Vol. 11:851-858.

 

Shi Jun, Pfister M, Jenkins SG, Chapel Sunny, Barrett JS, Port RE, Howard D. 2005. Relationships Between Pharmacodynamic Predictor Variables and Efficacy of Telithromycin in Patients with Community-acquired Pneumonia. Clinical Pharmacokinetics. Vol. 44:317-329.

 

Meka VG, Pillai S, Cooke A, Venkataraman L, Eliopoulos GM, Moellering Jr RC, Jenkins SG. 2004. Reversion to Susceptibility in a Linezolid-resistant Isolate of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. Vol. 54: 818-820.

 

Jenkins, SG. 2004. Resistance Trends in Staphylococcus aureus (PROTEKT Years 1-3 [1999-2002]). Journal of Chemotherapy. Vol.16 (Suppl 6):83-91.

 

Farrell DJ, Jenkins S, Reinert RR. 2004. Global Distribution of Streptococcus pneumoniae Serotypes Isolated from Paediatric Patients during 1999-2000 and the In Vitro Efficacy of Telithromycin and Comparators. Journal of Medical Microbiology. Vol. 53:1109-1117.

 

Farrell DJ, Jenkins SG. 2004. Distribution across the USA of Macrolide Resistance Mechanisms among Streptococcus pneumoniae Isolates Collected from patients with Respiratory Tract Infections: PROTEKT US 2001-2002. Journal of Antimicrobial Chemotherapy. Vol. 54:i17-i22.

 

Golan Y, McDermott LA, Jacobus NV, Goldstein EJC, Finegold S, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Rihs J, Iannini P, Gorbach SL, Snydman DR. 2003. Emergence of Fluoroquinolone Resistance among Bacteroides species. Journal of Antimicrobial Chemotherapy. Vol. 52:208-213.

 

Pinchoff RJ, Kaufman SS, Magid MS, Erdman DD, Gondolesi GE, Mendelson MH, Tane K, Jenkins SG, Fishbein TM, Herold BC. 2003. Adenovirus Infection in Pediatric Small Bowel Transplantation Recipients. Transplantation. Vol. 76:183-189.

 

Donnelly MJ, Herold BC, Jenkins SG, Daum RS. 2003. Obstacles to the Elimination of Haemophilus influenzae Type b Disease: Three Illustrative Cases. Pediatrics. Vol. 112:1465-1466.

 

Dawis AD, Isenberg HD, France KA, Jenkins SG. 2003. In Vitro Activity of Gatifloxacin Alone and in Combination with Cefepime, Meropenem, Piperacillin, and Gentamicin against Multi-Drug Resistant Organisms. Journal of Antimicrobial Chemotherapy. Vol. 51:1203-1211.

 

Snydman DRE, Jacobus NV, McDermott LA, Ruthazer R, Goldstein E, Finegold S, Harrell L, Hecht DW, Jenkins S, Pierson C, Venezia R, Rihs J, Gorbach SL. 2002. In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms. Antimicrobial Agents and Chemotherapy. Vol. 46:3276-3279.

 

Roe DE, Finegold SM, Citron DM, Goldstein EJ, Wexler HM, Rosenblatt JE, Cox ME, Jenkins SG, Hecht DW. 2002. Multilaboratory Comparison of Anaerobe Susceptibility Results Using 3 Different Agar Media. Clinical Infectious Diseases. Vol. 35 (Suppl 1):S40#150;S46.

 

Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Goldstein E, Finegold S, Harrell L, Hecht DW, Jenkins S, Pierson C, Venezia R, Rihs J, Gorbach SL. 2002. National Survey on the Susceptibility of B. fragilis Group: Report and Analysis of Trends for 1997-2000. Clinical Infectious Diseases. Vol. 1; 35 (Suppl 1):S126#150;S134.

 

Roe DE, Finegold SM, Citron DM, Goldstein EJ, Wexler HM, Rosenblatt JE, Cox ME, Jenkins SG, Hecht DW. 2002. Multilaboratory Comparison of Growth Characteristics for Anaerobes Using 5 Different Agar Media. Clinical Infectious Diseases. Vol. 35 (Suppl 1):S36-S39.

 

Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE. 2001. Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of the Bacteroides fragilis Group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus Species. Antimicrobial Agents and Chemotherapy. Vol. 45:1238-1243.

 

Queenan AM, Jenkins SG, Bush K. 2001 Cloning and Biochemical Characterization of FOX-5, an AmpC-type Plasmid Mediated Beta-lactamase from a New York City Klebsiella pneumoniae Clinical Isolate. Antimicrobial Agents and Chemotherapy. Vol. 45:3189-3194.

 

Jenkins SG. 2001. Infections Due to Anaerobic Bacteria and the Role of Antimicrobial Susceptibility Testing of Anaerobes. Reviews in Medical Microbiology. Vol. 12:1-12.

 

Hardy NM, Chiao J, Arora N, Mars R, Jenkins SG. 2000. Hepatitis C Virus in the Hemodialysis Setting: Detecting Viral RNA from Blood Port Caps by Reverse Transcription-polymerase Chain Reaction. Clin Nephrol. Vol. 54:143-146.

 

Pichichero M, Reiner S, Brook I, Gooch WM, Yamauchi T, Jenkins S, Sher L. 2000. Medical Management of Persistent and Recurrent Acute Otitis Media: A Practical Approach. Annals of Otology, Rhinology, and Laryngology. Vol. 109; Supplement 183:1-12.

 

Jones RN, Jenkins SG, Hoban DL, Pfaller MA, Ramphal R. 2000. In Vitro Efficacy of Six Cephalosporins Tested Against Enterobacteriaceae Isolated at 38 North American Medical Centers Participating in the SENTRY Antimicrobial Surveillance Program, 1997 #150; 1998. International Journal of Antimicrobial Agents. Vol. 15:111-118.

 

Jones RN, Jenkins SG, Hoban DL, Pfaller MA, Ramphal R. 2000. In Vitro Activity of Selected Cephalosporins and Erythromycin Against Staphylococci and Pneumococci Isolated at 38 North American Medical Centers Participating in the SENTRY Antimicrobial Surveillance Program, 1997 #150; 1998. Diagnostic Microbiology and Infectious Disease, Vol. 37:93-98.

 

Brook I, Gooch WM, Jenkins SG, Pichichero ME, Reiner SA, Sher L, Yamauchi T. 2000. Medical Management of Acute Sinusitis; Recommendations of a Clinical Advisory Committee on Pediatric and Adult Sinusitis. Annals of Otology, Rhinology, and Laryngology, Vol. 109:1#150;20.

 

Willey BM, Jones RN, McGeer A, Witte W, French G, Roberts RB, Jenkins SG, Nadler H, Low DE. 1999. Practical Approach to the Identification of Clinically Relevant Enterococcus species. Diagnostic Microbiology and Infectious Disease, Vol. 34, No. 3: 165-171.

 

Sing R F, Horton J M, Jenkins SG. 1999. Multidrug- Resistant Salmonella Associated with ampC Hyperproduction. Clinical Infectious Diseases, Vol. 29, No. 5:1348.

 

Snydman DR, Jacobus NV, McDermott LA, Supran S, Cuchural GJ, Finegold S, Harrell L, Hecht DW, Iannini P, Jenkins S, Pierson C, Rihs J, Gorbach L. 1999. Multicenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996. Antimicrobial Agents and Chemotherapy, Vol. 43, No. 10:2417-2422.

 

Halstead DC, Jenkins SG. 1998. Continuous Non-seasonal Epidemic of Respiratory Syncytial Virus Infection in the Southeast United States. Southern Medical Journal, Vol. 91, No. 5:434-436.

 

Ramos E, Gaudier FL, Herring LR, Del Valle GO, Jenkins S, Briones D. 1997. Group B Streptococcus Colonization in Pregnant Diabetic Women. Obstetrics and Gynecology. Vol. 89, No. 2:257-260.

 

Doern GV, Brueggemann AB, Dunne WM, Jenkins SG, Halstead DC, McLaughlin JC. 1997. Four-day Incubation Period for Blood Culture Bottles Processed with the Difco ESP�� Blood Culture

System. J Clin Microbiol. Vol. 35: 1290-1292.

 

Jenkins SG. 1996. Mechanisms of Bacterial Antibiotic Resistance. New Horizons: The Science and Practice of Acute Medicine. Vol. 4, No. 3:321-332.

 

Fuchs PC, Barry AL, Brown SD, and the AST Surveillance Group. 1996. Survey of Antimicrobial Activity of Four Commonly Used Third Generation Cephalosporins Tested Against Recent Bacterial Isolates from Ten American Medical Centers, and Assessment of Disk Diffusion Test Performance.

Diagnostic Microbiology and Infectious Diseases. Vol. 24:213-219.

 

Barry AL, Fuchs PC, Thornsberry C, McLaughlin JC, Jenkins SG, Hardy DJ, Allen SD. 1996. Methods of Measuring Susceptibility of Anaerobic Bacteria to Trovafloxacin, Including Quality Control Parameters. European Journal of Clinical Microbiology and Infectious Diseases. Vol. 15:116-118.

 

Bui MM, Jenkins SG. June, 1996. Clinical Infectious Disease Testing by Amplification Technology. Jacksonville Medicine. 247-250

 

Snydman DR, McDermott L, Cuchural Jr. GJ, Hecht DW, Iannini PB, Harrell E, Jenkins SG, O#146;Keefe JP, Pierson CL, Rihs J, Yu V, Finegold SM, Gorbach SL. 1996. Analysis of Trends in

Antimicrobial Resistance for Clinical Isolates of Bacteroides species from 1990-1994. Clinical Infectious Diseases. Vol. 23; Supplement 1:S54-S65.

 

Jenkins SG. 1996. Changing Spectrum of Uropathogens: Implications for Treating Complicated UTI#146;s; Epidemiology, Virulence, and Resistance Issues. The Journal of Critical Illness. Vol. 11, No. 11:S7-S13.

 

Jenkins SG. 1995. Evaluation of New Technology in the Clinical Microbiology Laboratory. Diagnostic Microbiology and Infectious Diseases. Vol. 23, Nos. 1-2:53-60.

 

Jenkins SG. 1995. Update on Laboratory Diagnosis of HIV Infection and Associated Infectious Diseases. Jacksonville Medicine. Vol. 46, No. 5:203-207.

 

Jenkins SG. 1995. Evaluation of New Technology in the Clinical Microbiology Laboratory. Clinical Performance and Quality Health Care. Vol. 3, No. 2:93-99.

 

Jenkins SG, Lewis JW. 1995. Synergistic Interaction Between Ofloxacin and Cefotaxime Against Common Clinical Pathogens. Infection. Vol. 23, No. 3:154-161.

 

Vandevelde AG, Jenkins SG, Hardy PR. 1995. Sclerosing Osteomyelitis and Infection of Surrounding Tissues with Actinomyces naeslundii. Clinical Infectious Diseases. Vol. 20, No. 4:

1037-1039.

 

Rathore MH, Jenkins SG, Williams E. 1995. Non-Typhoidal Salmonella Infections in Northeast Florida. Southern Medical Journal. Vol. 88, No. 8:840-841.

 

Waites K, Rand K, Jenkins SG, Yangco B, Brookings E, Gaskins D, Lewis J, Halkias K. 1994. Multicenter In Vitro Comparative Study of Fluoroquinolones after Four Years of Widespread Clinical

Use. Diagnostic Microbiology and Infectious Diseases, Vol. 19, No. 1:181-189.

 

Rathore MH, Jenkins SG. 1993. Group A Beta-Hemolytic Streptococcus: Issue of Resistance. The Pediatric Infectious Disease Journal. Vol. 12, No. 4:354-355.

 

Jenkins SG. 1993. Modern Hepatitis Tests: What do They Mean? Jacksonville Medicine. Vol. 44, No. 4:162-166.

 

Jenkins SG. 1993. Update on Laboratory Diagnosis of HIV Infection and Associated Infectious Diseases. Jacksonville Medicine. Vol. 44, No. 6:269-272.

 

Ponte R, Jenkins SG. 1992. Fatal Chromobacterium violaceum Infections Associated with Exposure to Stagnant Waters. The Pediatric Infectious Disease Journal, Vol. 11, No. 7:583-586.

 

Vandevelde AG, Jenkins SG. 1992. Evaluating the Microbiologic Ecology and Antimicrobial Susceptibilities Within the Hospital: A Streamlined Approach. Clinical Microbiology Newsletter, Vol. 14, No. 24:185-187.

 

Jenkins SG. 1992. Antimicrobial Susceptibility Tests for B-lactam/B-lactamase Inhibitors: Predictors of Clinical Efficacy? Clinical Microbiology Newsletter, Vol. 14, No. 12:89-93.

 

Jenkins SG. 1991. Tuberculosis Control and Immunizations for Prevention of Infectious Diseases in the Elderly. Jacksonville Medicine, Vol. 42, No. 4:150-156.

 

Murray BE, Singh KV, Markowitz SM, Lopardo HA, Patteson JE, Zervos MJ, Rubeglio E, Eliopoulos GM, Rice LB, Goldstein FW, Jenkins SG, Caputo GM, Nasnas R, Moore LS, Wong ES, Weinstock

G. 1991. Evidence for Clonal Spread of a Single Strain of Beta-lactamase-producing Enterococcus faecalis to Six Hospitals in Five States. Journal of Infectious Diseases, Vol. 163, No. 4:780-785.

 

Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CA. 1990. Quality Control Criteria for Testing the Susceptibility of Anaerobic Bacteria to Meropenem. Journal of Clinical Microbiology, Vol. 28, No. 12:2805-2806.

 

Jenkins SG. 1990. Approaches to Antibiograms and Formulary-Based Antibiotic Reporting. Clinical Microbiology Newsletter, Vol. 12, No. 4:30-32.

 

Day D, Mangi R, Jenkins SG, Ivey MF. 1989. A Multicenter Model for Examining in Vitro Susceptibilities of Bacteria to Antibiotics. Hospital Formulary, Vol. 24, No. 9:513-523

 

Neu HC, Andriole VT, Jenkins SG, Moleski RJ, Wiernik PH. 1989. P & T Committee Review of Cefoperazone Sodium: Cost-Effective Agent against Nosocomial Infection. Hospital Formulary, Vol. 24, Supplement B:7-10.

 

Jenkins SG. 1989. Activity of Cefotaxime/Desacetylcefotaxime with Aminoglycosides Against Gram Negative Pathogens - An Example of Interactive Synergy. Diagnostic Microbiology and

Infectious Diseases, Vol. 12, No. 1 (Supplement A: 51-55.

 

Abramson N, Jenkins SG. 1988. False Positive Serologic Tests and Serum Sickness. British Journal of Haematology, Vol. 70:388-389.

 

Jenkins SG. 1988. Comparative Susceptibility Patterns of Common Clinical Isolates to Cefoperazone - 1981 to 1987. American Journal of Medicine, Vol. 85, No. 1A:52-55.

 

Jenkins SG. 1988. Laboratory Diagnosis of HIV Infection. Jacksonville Medicine, Vol. 39, No. 6:13-14.

 

Jenkins SG. 1988. Rat-Bite Fever. Clinical Microbiology Newsletter. Vol. 10, No. 8:57-59.

 

Jenkins SG. 1987. Multidisciplinary Input Into Hospital Antibiotic Formulary Decisions. Clinical Microbiology Newsletter, Volume 9, No. 20:160-163.

 

Jenkins SG, Birk RJ, Zabransky RJ. 1982. Differences in Susceptibilities of Species of the Bacteroides fragilis group to Several Beta-Lactam Antibiotics: Indole Production as an Indicator of Resistance. Antimicrobial Agents and Chemotherapy. Vol. 22, No. 4:628-634.

Honors and Awards

Rensselaer Polytechnic Institute Award for Math and Science, 1966